Anna V Chernatynskaya
Overview
Explore the profile of Anna V Chernatynskaya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen J, Liu C, Chernatynskaya A, Newby B, Brusko T, Xu Y, et al.
J Immunol
. 2023 Dec;
212(2):258-270.
PMID: 38079221
Oxidants participate in lymphocyte activation and function. We previously demonstrated that eliminating the activity of NADPH oxidase 2 (NOX2) significantly impaired the effectiveness of autoreactive CD8+ CTLs. However, the molecular...
2.
Chen J, Chernatynskaya A, Li J, Kimbrell M, Cassidy R, Perry D, et al.
Sci Rep
. 2017 Sep;
7(1):10835.
PMID: 28883439
T lymphocytes constitute a major effector cell population in autoimmune type 1 diabetes. Despite essential functions of mitochondria in regulating activation, proliferation, and apoptosis of T cells, little is known...
3.
Looney B, Chernatynskaya A, Clare-Salzler M, Xia C
J Blood Disord Transfus
. 2016 Jan;
5(4).
PMID: 26779386
Dendritic cells (DC) have been investigated as a cell-based therapy for Type 1 Diabetes (T1D). BM-DC expanded with GM-CSF and IL-4 is typically cultured with fetal bovine serum (FBS). The...
4.
Xia C, Peng R, Chernatynskaya A, Yuan L, Carter C, Valentine J, et al.
J Immunol
. 2014 Jun;
193(3):1024-34.
PMID: 24973447
Increasing evidence suggests that type 1 IFN (IFN-αβ) is associated with pathogenesis of Th1-mediated type 1 diabetes (T1D). A major source of IFN-αβ is plasmacytoid dendritic cells (pDCs). In this...
5.
Xia C, Chernatynskaya A, Looney B, Wan S, Clare-Salzler M
J Immunol Res
. 2014 Apr;
2014:326708.
PMID: 24741590
Anti-CD3 antibody has been employed for various immune-mediated disorders. However, whether anti-CD3 administration leads to rapid metabolic alternation has not been well investigated. In the current study, we studied how...
6.
Xia C, Chernatynskaya A, Wasserfall C, Wan S, Looney B, Eisenbeis S, et al.
BMC Immunol
. 2012 Dec;
13:70.
PMID: 23237483
Background: ATG has been employed to deplete T cells in several immune-mediated conditions. However, whether ATG administration affects naïve and memory T cell differently is largely unknown. THE CONTEXT AND...
7.
Chernatynskaya A, Looney B, Hu H, Zhu X, Xia C
Diabetes Metab Res Rev
. 2011 Nov;
27(8):809-12.
PMID: 22069264
Background: Thioredoxin as a biological antioxidant plays an important role in regulating the redox system. The administration of recombinant thioredoxin has been demonstrated to be anti-inflammatory. In this study, the...
8.
Chernatynskaya A, DeLeeuw L, Trent J, Brown T, Lane A
Org Biomol Chem
. 2009 Nov;
7(23):4981-91.
PMID: 19907790
The solution structure of a 14 base-pair non-self complementary DNA duplex containing the consensus-binding site of the yeast transcription factor Mbp1 has been determined by NMR using a combination of...